← Open Payments lookup

FOLAKE OREHIN: Open Payments

NPI 1619582087 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$309 in 16 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $55 · 2025 $309

Food & beverage: $309
CompanyPaymentsAmount
Gilead Sciences, Inc.4$80
Lilly USA, LLC2$52
Novo Nordisk Inc2$43
Exact Sciences Corporation2$40
Esperion Therapeutics, Inc.2$33
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$30
AstraZeneca Pharmaceuticals LP1$17
PFIZER INC.1$15

Products named: Cologuard Collection Kit, NEXLETOL, XIFAXAN, Ozempic, ZEPBOUND, MOUNJARO, Yeztugo, AIRSUPRA.

Industry payments across TX — which companies pay providers there.